Veterinary Diagnostics Market Oveview
The Global Veterinary Diagnostics Market reached USD 8.82 billion in 2025 and is projected to witness lucrative growth by reaching up to USD 15.75 billion by 2033. The global veterinary diagnostic smarket is expected to exhibita CAGR of 8.7% during the forecast period (2026-2033).
Veterinary diagnostics are crucial for animal health, detecting health issues before they become serious and allowing for faster diagnosis and treatment planning. Traditional diagnosis is the examination of blood, tissue, urine, or faeces for the presence of proteins, antibodies, disease, or general markers of overall health. Digital diagnostics unleash the technology's preventative capacity by spotting trends in wellness data that human specialists may overlook, opening up new avenues for early disease diagnosis. Artificial intelligence and other cutting-edge approaches mean more potential to spot danger patterns in ever-increasing data volumes.
Additionally, the rise of veterinary diseases, growing number of pets adopted worldwide and other factors helps to grow the veterinary diagnostics market size. Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market is seeing an increase in demand from North American regions with significant key players like Ringbio, Virbac, PetDx, and others actively operating in the market.
Veterinary Diagnostics Market Key Takeaways
- North America emerged as a leading regional market in 2025, supported by advanced veterinary healthcare infrastructure, rising companion animal ownership, widespread pet insurance coverage, and increasing adoption of molecular diagnostics and point-of-care testing.
- Asia-Pacific is expected to register the fastest growth during the forecast period, driven by expanding livestock production, increasing awareness of animal disease surveillance, government-led animal health initiatives, and rapid growth in companion animal healthcare across China, India, and Southeast Asia.
- Companion animal diagnostics continue to gain momentum as pet owners increasingly seek preventive healthcare, early disease detection, and routine wellness screening, boosting demand for advanced veterinary diagnostic solutions.
- Livestock disease surveillance is becoming a strategic priority worldwide, with governments and producers investing in rapid diagnostic technologies to prevent outbreaks, improve food safety, and minimize economic losses.
- Point-of-care diagnostic technologies are transforming veterinary practice by enabling faster clinical decision-making, reducing laboratory turnaround times, and improving treatment outcomes in clinics and field settings.
- Advances in molecular diagnostics, AI-powered imaging, and digital pathology are enhancing diagnostic accuracy, supporting precision veterinary medicine, and expanding opportunities for veterinary diagnostic laboratories worldwide.
Veterinary Diagnostic Market Scope
| Metrics | Details |
| CAGR | 8.7% |
| Size Available for Years | 2025-2032 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Product Type, Animal Type,Technology, Application, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Type Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For More Insights about the Market Request Free Sample
Veterinary Diagnostic Market Trends
Increasing Number of Pets Adopted Worldwide will Rise the Market Growth
The growing number of pets adopted worldwide fuels the global veterinary diagnostics market. For instance, according to ASPCA, approximately 6.3 million companion animals enter U.S. animal shelters nationwide every year. Of those, approximately 3.1 million are dogs and 3.4 million are cats. Approximately 4.1 million shelter animals are adopted each year (2 million dogs and 2.1 million cats).
Additionally, Pets, such as dogs and cats, are also known for offering companionship and emotional support. Especially during difficult times, such as the COVID-19 pandemic, when people were spending more time at home and feeling isolated, individuals craved the company of a pet. Numerous studies have demonstrated that engaging with pets can help people cope with stress, anxiety, and depression.
As individuals become more aware of the benefits of pets for mental health, more people sought out pets to boost their well-being. Pet adoption has increased due to the popularity of pet-focused material on social media platforms. People were more interested in owning pets after seeing adorable and comforting pet videos and photographs. Thus above factors helps to drive the market growth.
The Rising Prevalence of Pet Animal Diseases
Globally, the rising prevalence of pet animal illnesses and their transmission to humans supported market expansion. The rising prevalence of zoonotic illnesses and their transmission to humans, increased pet adoptions and the number of veterinary healthcare professionals, and more research into veterinary disease diagnosis are driving market expansion.
For instance, according to a study published in the Faculty Reviews 2022, more than 63% of human infections have zoonotic origins, whereas the other 45% have either developed from non-zoonotic sources or co-evolved with humans. Several zoonotic-origin illnesses have recently resulted in an outbreak and have damaged the global human population. As a result, the rise of pet animal diseases contributes to market growth.
The Increasing Pet Care Costs and Shortage of Veterinarians
However, the increasing pet care costs and shortage of veterinarians are anticipated to hinder the growth of the veterinary diagnostics market. The U.S. Bureau Of Labor Statistics Occupational Employment and Wages, in May 2021, indicated that only 77,260 veterinarians are practicing for the 90.5 million U.S households with pets.
Also, the average cost of owning a pet can range from $700 to $1,100 per year, as per the type and size of pet, according to the American Society for the Prevention of Cruelty to Animals. Thus, it will slow the global veterinary diagnostics market growth in the forecast period.
Why does this report matter in 2026?
In 2026, the veterinary diagnostics market is being transformed by rising companion animal ownership, increasing livestock disease surveillance, and growing demand for rapid, accurate diagnostic testing. Veterinary clinics, hospitals, and livestock producers are investing in advanced diagnostic technologies to enable early disease detection, improve treatment outcomes, and strengthen animal health management.
This report helps diagnostic manufacturers, veterinary hospitals, animal health companies, investors, and livestock producers identify the fastest-growing diagnostic technologies, animal segments, disease applications, and regional opportunities. It also highlights how point-of-care testing, molecular diagnostics, AI-enabled diagnostic platforms, and digital veterinary healthcare are reshaping clinical workflows and diagnostic capabilities.
Competitive advantage increasingly depends on diagnostic accuracy, testing speed, product innovation, regulatory compliance, and strong distribution networks. The report therefore evaluates diagnostic instruments, consumables, laboratory services, and digital diagnostic solutions, providing a comprehensive assessment of market growth, investment potential, and long-term revenue opportunities.
Veterinary Diagnostics Market White Space & Investment Opportunities
- Expand point-of-care diagnostic platforms for veterinary clinics, rural practices, and mobile veterinary services to enable rapid on-site disease detection.
- Develop AI-powered diagnostic software that integrates laboratory results, imaging, and clinical data to improve diagnostic accuracy and treatment decisions.
- Increase investments in molecular diagnostics, PCR-based testing, and multiplex assays for rapid detection of infectious diseases in companion animals and livestock.
- Introduce affordable diagnostic solutions tailored for emerging markets where access to advanced veterinary laboratory infrastructure remains limited.
- Strengthen preventive healthcare offerings through routine screening, disease surveillance programs, and herd health monitoring services for livestock producers.
- Localize manufacturing, distribution, and veterinary laboratory networks across Asia-Pacific, Latin America, the Middle East, and Africa to improve accessibility, reduce costs, and support growing demand for animal healthcare diagnostics.
Veterinary Diagnostics Market Buyer Decision-Making Criteria
Buyers evaluate veterinary diagnostics based on diagnostic accuracy, testing speed, ease of use, sensitivity, specificity, and overall cost-effectiveness. Veterinary hospitals, clinics, laboratories, and livestock producers also consider product reliability, regulatory approvals, and compatibility with existing laboratory workflows. Rapid turnaround time and comprehensive disease detection capabilities play a critical role in purchasing decisions.
For diagnostic platforms, customers assess instrument performance, consumable availability, technical support, after-sales service, software integration, and maintenance requirements. Scalability, automation, and connectivity with digital veterinary management systems are becoming increasingly important, particularly for high-volume laboratories and veterinary hospitals.
Procurement decisions are increasingly influenced by veterinarians, laboratory managers, livestock operators, and healthcare administrators who prioritize clinical accuracy, operational efficiency, and long-term value. Suppliers offering innovative diagnostic technologies, strong technical support, and broad disease-testing portfolios are better positioned to secure long-term customer relationships.
Veterinary Diagnostics Market Economic & Investment Analysis
The veterinary diagnostics market is experiencing steady investment driven by increasing animal healthcare spending, rising demand for companion animal diagnostics, expanding livestock disease surveillance, and growing awareness of preventive veterinary care. Market growth is supported by continuous innovation in molecular diagnostics, immunoassays, point-of-care testing, and digital diagnostic technologies.
Investment is increasingly directed toward automated laboratory systems, AI-enabled diagnostic platforms, molecular testing capabilities, and veterinary laboratory expansion. Companies are also strengthening manufacturing capacity, regional distribution networks, and digital health integration to improve diagnostic accessibility and operational efficiency.
Growing demand for early disease detection, zoonotic disease monitoring, and precision veterinary medicine continues to create attractive long-term investment opportunities across companion animal and livestock healthcare markets.
Veterinary Diagnostics Market Investment Trends
- Expansion of veterinary diagnostic laboratories, point-of-care testing facilities, and regional distribution networks to improve access to advanced animal healthcare diagnostics.
- Strategic acquisitions and partnerships focused on molecular diagnostics, veterinary imaging, AI-powered diagnostic platforms, and laboratory automation technologies.
- Increasing investment in rapid diagnostic tests, PCR platforms, multiplex assays, and next-generation sequencing for infectious disease detection.
- Capital allocation toward AI-enabled diagnostics, cloud-connected laboratory systems, and digital veterinary healthcare platforms to improve clinical decision-making.
- Growing investment in automated laboratory equipment, advanced biomarker research, and preventive animal health solutions to support precision veterinary medicine and livestock disease surveillance.
Veterinary Diagnostic Market Segment Analysis
The global veterinary diagnostics market is segmented based on product type, animal type, technology, application, end user and region.
The Analyzers Segment Accounted for Approximately 41.07% of the Veterinary DiagnosticsMarket Share
Veterinary diagnostics analyzers are extremely important in the field of veterinary medicine. These advanced tools are meant to perform numerous diagnostic tests and analyses on animal samples, assisting veterinarians in accurately diagnosing diseases and monitoring their patients' health state.
Additionally, the strategies followed by companies helps to boost the segment growth. For instance, on December 21, 2022, EKF Diagnostics, a global in vitro diagnostics firm, has announced the launch of a new version of their Lactate Scout analyzer, specifically tailored for use in veterinary settings. Lactate Scout Vet employs the same tried-and-true technology that was first created to equip professional sports coaches and athletes with a precise and user-friendly handheld lactate test.
Additionally, in Feburary 2023, VolitionRx Limited, an epigenetics firm, has announced that their Nu.Q Vet Cancer Test is currently available for pre-order through Heska Corporation to veterinarians at the point-of-care. Heska's Nu.Q Canine Cancer Screen and Monitor Test will be run using Heska's proprietary Element i+ Immunodiagnostic Analyzer, a point-of-care platform that gives veterinarians with on-site testing that is speedy, accurate, low cost, and simple to use. Thus, the aforementioned variables drive segment expansion.
Veterinary Diagnostic Market Geographical Share
North America Accounted for Approximately 43.4% of the Market Share in 2022
Growing pet adoptions, increased expenditure on pet health, and product releases by companies all contribute to the region's success. For instance, in July 2022, PSIvet, the nation's largest veterinary group purchasing organisation, has announced an agreement with Bionote USA, a developer of quantitative, point-of-care veterinary analyzers and biomarker assays.
The collaboration will lower the cost of Bionote USA's Vcheck series of analyzers and tests for PSIvet's 5,000-plus veterinary practises. The Vcheck V200 analyzer and tests can be utilised as a supplement to a veterinary clinic's point-of-care lab for speedier diagnosis and treatment plan initiation, as well as significant cost savings per test.
Additionally, on April 19, 2022, Zoetis announced the inclusion of artificial intelligence (AI) blood smear testing to its multi-purpose platform, Vetscan ImagystTM, as its latest diagnostic breakthrough. Vetscan Imagyst, which will be available in September 2020, is a first-of-its-kind technology with a wide range of applications, including AI faecal analysis, digital cytology image transfer, and now AI blood smear - ultimately assisting veterinarians in broadening in-clinic diagnostic offerings to provide the best possible care for dogs and cats. Thus, the aforementioned reasons promote the region's growth.
Veterinary Diagnostics Market Key Players
The major global players in the veterinary diagnostics market Zoetis, Thermo Fisher Scientific, Covetrus, Inc, PetDx, HORIBA UK Limited, Ringbio, Virbac, IDVet, Abaxis, Heska Corporation and others.
Key Developments
- On April 18, 2026, global veterinary healthcare initiatives emphasized the rapid adoption of AI-enabled and molecular diagnostic platforms across companion animal and livestock healthcare. Increasing focus on zoonotic disease surveillance, preventive care, and rapid in-clinic testing accelerated investments in veterinary diagnostics infrastructure worldwide.
- On March 8, 2026, IDEXX Laboratories expanded its advanced veterinary diagnostic portfolio with increased deployment of next-generation in-clinic analyzers and cancer screening solutions for companion animals. The expansion supports faster disease detection, improved workflow efficiency, and growing demand for preventive veterinary healthcare services.
- On February 2026, BioVenic expanded its veterinary molecular diagnostic development services, strengthening support for research teams developing next-generation animal disease testing platforms. The initiative aims to accelerate commercialization of precise molecular diagnostic tools for infectious and chronic veterinary diseases.
- On January 2026, veterinary industry reports highlighted strong growth in the global veterinary diagnostics market driven by rising pet ownership, increasing livestock disease monitoring, expanding use of point-of-care diagnostics, and growing adoption of advanced molecular and AI-based testing technologies.
- On December 2025, the ICAR-Indian Veterinary Research Institute organized an advanced training program focused on serological and molecular diagnostic techniques for livestock and poultry diseases. The initiative supported wider adoption of modern veterinary diagnostic technologies across emerging markets.
- On November 2025, veterinary diagnostic companies increased investments in rapid infectious disease testing solutions amid rising concerns over transboundary livestock diseases and zoonotic infections. Expanding disease surveillance programs strengthened demand for high-throughput diagnostic systems globally.
- On September 2025, Zomedica strengthened its veterinary diagnostics intellectual property portfolio with multiple newly issued patents covering its TRUVIEW digital cytology and TRUFORMA diagnostic platforms. The development reinforced innovation in automated veterinary diagnostic technologies and in-clinic testing systems.
- On June 2025, bioMérieux launched VETFIRE™, a rapid PCR veterinary diagnostic test capable of detecting multiple equine respiratory pathogens within minutes. The launch strengthened rapid molecular diagnostics adoption and supported improved antimicrobial stewardship in veterinary healthcare.
- On March 2025, Antech introduced trūRapid™ FOUR, a rapid in-house veterinary diagnostic screening test for canine vector-borne diseases including Lyme disease, Ehrlichia, Anaplasma, and heartworm. The product launch enhanced point-of-care diagnostic capabilities for veterinary clinics globally.
- On January 2025, IDEXX Laboratories launched IDEXX Cancer Dx, a low-cost blood test designed for early detection of canine lymphoma as part of routine wellness screening programs. The innovation strengthened the growing role of oncology diagnostics in companion animal healthcare.
Analyst View on Veterinary Diagnostic Market
- Molecular diagnostics, point-of-care testing, and AI-enabled diagnostic solutions will outpace traditional diagnostic methods as veterinary practices prioritize early disease detection and faster clinical decision-making.
- Companion animal diagnostics will continue to generate the largest revenue share, while livestock diagnostics will witness strong growth driven by disease surveillance, food safety, and herd health management.
- Preventive healthcare and routine wellness screening will increasingly drive diagnostic testing volumes as pet ownership rises and awareness of animal health continues to improve.
- Digital pathology, telemedicine integration, and cloud-based laboratory information systems will become standard components of modern veterinary diagnostic workflows rather than optional technologies.
- Regional diagnostic laboratory expansion and point-of-care testing availability will become key competitive differentiators as veterinary providers seek faster turnaround times and improved access to advanced diagnostic services.
- Companies that combine innovative diagnostic technologies, comprehensive test portfolios, AI-powered analytics, and strategic partnerships with veterinary clinics and laboratories will be best positioned to capture long-term market growth.
Why Purchase the Report?
- To visualize the global veterinary diagnostics market segmentation based on product type, animal type, technology, application, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of veterinary diagnostics market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global veterinary diagnostics market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
